Trials / Completed
CompletedNCT00425997
Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
A 10-week Multicenter,Forced-titration Study Using 24-hr ABPM to Evaluate the Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Treatment Regimen vs Conventional Treatment Regimen With Amlodipine and Hydrochlorothiazide (HCTZ) in Patients With Stage 2 Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 480 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of valsartan/hydrochlorothiazide versus amlodipine and hydrochlorothiazide in patients with Stage 2 hypertension using 24-hr ambulatory blood pressure monitoring (ABPM)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan/HCTZ | |
| DRUG | amlodipine | |
| DRUG | HCTZ |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2007-01-24
- Last updated
- 2011-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00425997. Inclusion in this directory is not an endorsement.